Longitudinal Analysis of T and B Cell... - Lung Conditions C...

Lung Conditions Community Forum

56,007 members66,637 posts

Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.

2greys profile image
2 Replies

Severe COVID-19 is associated with profound lymphopenia and an elevated neutrophil to lymphocyte ratio. We applied a novel dimer avoidance multiplexed polymerase chain reaction next-generation sequencing assay to analyze T (TCR) and B cell receptor (BCR) repertoires. Surprisingly, TCR repertoires were markedly diminished during the early onset of severe disease but recovered during the convalescent stage. Monitoring TCR repertoires could serve as an indicative biomarker to predict disease progression and recovery. Panoramic concurrent assessment of BCR repertoires demonstrated isotype switching and a transient but dramatic early IgA expansion. Dominant B cell clonal expansion with decreased diversity occurred following recovery from infection. Profound changes in T cell homeostasis raise critical questions about the early events in COVID-19 infection and demonstrate that immune repertoire analysis is a promising method for evaluating emergent host immunity to SARS-CoV-2 viral infection, with great implications for assessing vaccination and other immunological therapies.

frontiersin.org/articles/10...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Patk1 profile image
Patk1

Grwat research going on.thanku for sharing

Mavary profile image
Mavary

It sounds a bit complicated but hopeful. I would love to be able to go back shopping as normal but are we going to have any shops to go to. We’ve got Edinburgh Woolen Mills closing, Double Two have closed and that’s only the ones I know of near me. It’s quite scarey.

Not what you're looking for?

You may also like...

Blood clotting a significant cause of death in patients with COVID-19.

A study led by clinician scientists at RCSI University of Medicine and Health Sciences has found...

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that...

T-cell Covid immunity 'present in adults six months after first infection'.

Cellular (T-cell) immunity against the virus that causes Covid-19 is likely to be present within...

New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients.

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against...

Phase 2/3 trial of Oxford COVID-19 vaccine in healthy older adults finds it is safe and provokes immune response.

The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy...